FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/080754 [Registered on: 18/02/2025] Trial Registered Prospectively
Last Modified On: 10/02/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) [Therapeutic]  
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Efficacy of mustadi ghanvati with and without udvartana in hyperlipidemia on lipid profile 
Scientific Title of Study   Randomized Controlled Trial of Efficacy of Mustadi Ghanvati With and Without Udvartana in Medoroga With Special Reference to Hyperlipidemia on Lipid Profile 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Mayuri Madhukar Mungale 
Designation  PG Scholar 
Affiliation  Government Ayurved College and Hospital, Nagpur 
Address  Department of Kayachikitsa OPD no 1, Government Ayurved College and Hospital , Sakkardara Square ,Nagpur Nagpur Maharashtra 440024 India
Department of Kayachikitsa OPD no 1, Government Ayurved College and Hospital , Sakkardara Square ,Nagpur Nagpur Maharashtra 440024 India
Nagpur
MAHARASHTRA
440024
India 
Phone  8378889923  
Fax    
Email  mayurimungale1998@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Ashish Thatere 
Designation  Assistant Professor 
Affiliation  Government Ayurved College and Hospital, Nagpur 
Address  Department of Kayachikitsa OPD no 1, Government Ayurved College and Hospital , Sakkardara Square ,Nagpur Nagpur Maharashtra 440024 India
Department of Kayachikitsa OPD no 1, Government Ayurved College and Hospital , Sakkardara Square ,Nagpur Nagpur Maharashtra 440024 India
Nagpur
MAHARASHTRA
440024
India 
Phone  9423406821  
Fax    
Email  ashish.thatere@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Mayuri Madhukar Mungale 
Designation  PG Scholar 
Affiliation  Government Ayurved College and Hospital, Nagpur 
Address  Department of Kayachikitsa OPD no 1, Government Ayurved College and Hospital , Sakkardara Square ,Nagpur Nagpur Maharashtra 440024 India
Department of Kayachikitsa OPD no 1, Government Ayurved College and Hospital , Sakkardara Square ,Nagpur Nagpur Maharashtra 440024 India
Nagpur
MAHARASHTRA
440024
India 
Phone  8378889923  
Fax    
Email  mayurimungale1998@gmail.com  
 
Source of Monetary or Material Support  
Government Ayurveda College and Hospital, Raje Raghuji Nagar, Sakkardara Square, Nagpur 440024 
 
Primary Sponsor  
Name  Government Ayurveda College and Hospital, Nagpur 
Address  Government Ayurved College and Hospital , Sakkardara Square ,Nagpur Nagpur Maharashtra 440024 India Nagpur 
Type of Sponsor  Other [Government Ayurved College and Hospital] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Mayuri Madhukar Mungale  Government Ayurved College and Hospital Nagpur  Department of Kayachikitsa OPD no 1, Government Ayurved College and Hospital , Sakkardara Square ,Nagpur Nagpur Maharashtra 440024 India
Nagpur
MAHARASHTRA 
8378889923

mayurimungale1998@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee Government Ayurved College,Nagpur  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E785||Hyperlipidemia, unspecified. Ayurveda Condition: MEDOROGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-udvartanam, उद्वर्तनम् (Procedure Reference: Kale V. S. Charak Samhita, Chaukhambha Sanskrit pratishthan, 2016, Sutraasthana, Adhyay no. 21/21, page.no.325, Procedure details: Purvakarma Bladder & bowel should be emptied. Patient is asked to lie-down on Abhyanga table with minimum cloths. Pradhana Karma Udavartana will be done with mustadi Churna. Churna will be applied to whole body in upward direction and opposite to hair root. Udvartana should begin from legs arms chest abdomen and back and gluteal region. Udvartana should be done in a clockwise and anticlockwise motion over the joints chest palms soles of the feet. Time At morning before bath. Dose As per requirement for 20 min. Duration 30 days. Paschata Karma After udvartana patient will be wiped with sterile cloth and asked to take rest for 15 minutes. Patient will be asked to take sukhoshnajala snana.)
(1) Medicine Name: Mustadi Ghanvati, Reference: Kale V. S. Charak Samhita, Chaukhambha Sanskrit pratishthan, 2016, Sutraasthana, Adhyay no. 23/12-14, page.no.325, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/Tablets, Dose: 1(g), Frequency: tds, Duration: 30 Days
2Comparator ArmDrugClassical(1) Medicine Name: Mustadi Ghanvati, Reference: Kale V. S. Charak Samhita, Chaukhambha Sanskrit pratishthan, 2016, Sutraasthana, Adhyay no. 23/12-14, page.no.325, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 1(g), Frequency: tds, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: Koshnajala), Additional Information: Charak asserted that all santarpanjanya vyadhis or overnutrition-related disorders could be cured with regular use of mustadi kwath. For improved efficacy and patient compliance the traditional mustadi kwath was changed and transformed into a ghanvati form
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Patients who are willing to participate in trial and ready to give written consent.Patient having minimum fifty percent symptoms of medoroga according to classics and fulfilling diagnostic criteria of this study.Male and females, aged between twenty to seventy years irrespective of caste religion socioeconomic and educational status.Patient whose lipid profile shows any one or both of the following diagnostic criteria of hyperlipidemia that is serum cholesterol 201 mg per dl upto 1000 mg per dl, Serum Triglycerides 151 mg per dl upto 1000 mg per dl will be selected.Patients of Medoroga having BMI more than 25 Kg per m2 and less than 40 Kg per m2.Patient with controlled HTN BP Systolic less than 150 and Diastolic less than 100 mmHg and DM having FBS less than 150 mg per dl and PMBS less than 250 mg per dl.Patient who had not participated in any research work since last six months will be included
 
 
ExclusionCriteria 
Details  Patients who are not willing to participate in trial and not ready to give written consent. Patients having age below 20 years and above 70 years.Patients who have uncontrolled HTN BP Systolic greater than 150 and Diastolic greater than 100 mmHg. Patients who have uncontrolled DM FBS greater than 150 mg per dl and PMBS greater than 250 mg per dl.Patients having history of serious cardiac disorders like myocardial infarction cardiac failure etc. and any other serious renal hepatic respiratory diseases etc. will also be excluded.Patients having a history of untreated thyroid disorders.Patients who are unfit for udvartana like skin disorders injury or wound hypersensitive.Drug induced hyperlipidemia like glucocorticoids induced hyperlipidemia.Pregnant females and lactating mothers.Who are currently participating in any other clinical trial from last 6 month. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To evaluate the efficacy of Mustadi Ghanvati with and without Udvartana in
the management of Medoroga w.s.r.t. hyperlipidemia on lipid profile.
To evaluate the efficacy of Mustadi Ghanvati with and without Udvartana in
management of Medoroga w.s.r.t. hyperlipidaemia on symptom scale of
Medoroga.
To evaluate the efficacy of Mustadi Ghanvati with and without Udvartana in
management of Medoroga w.s.r.t. hyperlipidaemia on anthropometric parameters. 
On 0th day, 16th day, 31st day
of trial 
 
Secondary Outcome  
Outcome  TimePoints 
To review and study literature of Medoroga as per Ayurvedic classics.
To review and study literature of hyperlipidaemia as per modern science 
On 0th day, 16th day, 31st day
of trial 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   01/03/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Plan of work

After Institutional Ethics Clearance of Government Ayurved College, Nagpur Screening of Population will be done from Patients in OPD, IPD of our hospital attached to institute. In the Clinical study 60 Patients of Medoroga with Hyperlipidemia will include. Assessment of lipid profile and clinical symptoms of Medoroga will be done. If patient fulfill the criteria of inclusion, subject would also give freedom to ask the questions and all questions would answer. If he/she agrees for participation in the study and found fit to include then that patient will be included in a study.

 

The treatment will be given to patient as follows:

Group A (Trial Group)

1) 0 Day assessment (Before treatment) on recruitment day

2) Udvartana with Mustadi Churna At morning before bath for 20 mins daily (for 15 days)  + Mustadi Ghanvati 500 mg 2 TID (3 g/day) With Lukewarm water Before meal (for 15 days)

3) Mid treatment assessment (on 16th day) Udvartana with Mustadi Churna At morning before bath for 20 mins daily (for next 15 days) + Mustadi Ghanvati 500 mg 2 TID (3 g/day) With Lukewarm water Before meal For next 15 days

4) Assessment after completion of treatment (On 31st day)


 

Group B(Control Group)

1)0 Day assessment (Before treatment) on recruitment day

2)Mustadi Ghanvati 500 mg 2 TID (3 g/day) With Lukewarm water Before meal (for 15 days)

3)Mid treatment assessment (on 16th day)

4)Mustadi Ghanvati 500 mg 2 TID (3 g/day) With Lukewarm water Before meal (For next 15 days)

5)Assessment after completion of treatment (On 31st day)


 

Medium of Dissertation: The dissertation will be written in English by using Ayurvedic terminology where ever necessary in Sanskrit.

Study Setting: OPD and IPD of hospital attached to institute.

Study Design: Randomized Controlled Trial

Duration of study: 18 months

Duration of Treatment: 30 days

Ethical Clearance: Clearance from Institutional Ethics committee of our Institute

Study Population:

All obese patients attending OPD, IPD of our institute will be considered in this study.

Patients in between age group of 20 – 70 years.

Patient will be diagnosed on the basis of lipid profile and symptoms of Medoroga according to Ayurvedic Classics.

Sample Size:

Sample size was calculated with the help of data published by Nadkarni MA, Vyas SN, Baghel MS, Ravishankar B. Randomized placebo-controlled trial of Mustadi Ghanavati in hyperlipidaemia.

 

Required Sample Size per group is 26

Considering 10% dropout/non-response, Hence Final Sample Size in each group is 30.

 

Physical characters will be assessed on the basis of following Questionnaires and Scales:

A)     OBJECTIVE CRITERIA:

1] ANTHROPOMETRIC CHARACTERS

1.Height                                                                        

             2.Weight                                                                                                 

             3.BMI                                                                               

             4.Abdominal circumference                                         

             5.Waist circumference                                         

6.Hip circumference                                               

             7.Waist Hip Ratio

8.Skinfold Thickness - a. Abdominal   b. Bicep    c. Triceps

 

2] CLINICAL PARAMETERS:

1.SPO2

2.Pulse Rate

3.Respiration Rate

4.Blood Pressure

5. Temperature

 

3] BIOCHEMICAL PARAMETERS:

            1. Lipid profile

            2. Blood sugar level fasting and Post Prandial

            3. Complete blood count

            4. Erythrocytes sedimentation rate

            5. Urine routine and microscopic

B)     OBJECTIVE CRITERIA:

1] Symptoms of Medoroga

2] Lipid Profile

3] BMI

4] Waist hip ratio, abdominal circumference and skin folds (abdominal, biceps & triceps)  

 

 

 

 

 
Close